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Abstract  Hypersensitivity  pneumonitis  (HP)  is  an  immune-mediated  syndrome  triggered  by
inhalation  of  a  wide  variety  of  allergens,  to  which  an  individual  has  previously  been  sensitized.
More than  200  agents  responsible  for  the  disease  have  already  been  identiﬁed;  however,  HP
occurs only  in  a  small  number  of  individuals  exposed  to  causal  antigens.  The  present  report
provides an  overview  of  the  role  of  antigen  role  in  HP,  highlighting  its  diversity,  research  meth-
ods, and  prevention  strategies,  as  well  as  the  impact  on  disease  prognosis  following  elimination
of antigen.  HP  is  an  underdiagnosed  disease  and,  therefore,  it  is  difﬁcult  to  accurately  esti-
mate its  incidence.  Triggering  antigens  can  be  divided  into  six  broad  categories:  bacteria,  fungi,
mycobacteria,  animal  and  plant  proteins,  chemicals,  and  metals,  represented  by  disease  pro-
totypes. The  identiﬁcation  of  causal  antigen  is  a  major  challenge;  it  is  impossible  to  obtain  in
about 30--60%  of  cases.  The  acute  form  of  HP,  with  early  detection  and  immediate  eviction  of
causal antigen,  tends  to  have  an  excellent  prognosis.  In  the  chronic  form,  partial  recovery  of
disease is  still  possible;  however,  some  cases  tend  to  progress  to  ﬁbrosis,  even  after  removal
from exposure.  In  conclusion,  HP  diagnosis  should  be  based  on  a  proactive  search  for  potential
antigen sources,  although  their  identiﬁcation  is  hampered  by  the  lack  of  standardized  methods
of demonstrating  the  speciﬁc  antigen  sensitization.  Antigen  avoidance  is  a  critical  determinant
in disease  prognosis.esa  d
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ypersensitivity  pneumonitis  (HP),  also  known  as  extrinsic
llergic  alveolitis,  is  an  immune-mediated  syndrome  that
esults  from  lung  parenchyma  and  small-caliber  respiratory
ract  inﬂammation.  This  reaction  is  secondary  to  repeated
nd  prolonged  speciﬁc  antigens  inhalation  to  which  an  indi-
idual  is  sensitized.1 More  than  200  antigens  have  already
een  identiﬁed  as  causal  agents  of  HP  and  these  can  be  found
n  the  workplace,  at  home,  and  in  recreational  activities.
he  huge  majority  are  derived  from  fungi,  bacteria,  pro-
ozoa,  and  animal  proteins,  or  even  low-molecular-weight
hemical  compounds.2 Clinical  presentation  and  disease
rogression  can  be  extremely  variable,  depending  on  the
ature  of  causal  agent,  exposure  duration,  and  intensity,  as
ell  as  individual  host  factors.1,3,4
The  incidence  and  prevalence  of  HP  are  difﬁcult  to  esti-
ate  accurately,  mostly  because  of  underdiagnosis,  which
ay  be  partly  explained  by  the  absence  of  widely  accepted
iagnostic  criteria.3,4 Additionally,  HP  prevalence  varies
rom  country  to  country  (and  even  within  the  same  coun-
ry),  according  to  geographical  conditions,  local  practices
agricultural  and  industrial),  and  host  risk  factors.3,5 For
xample,  epidemiologic  data  show  an  incidence  of  HP  in
urope  ranging  from  0.3  up  to  0.9  per  100  000  inhabitants.6--8
n  fact,  the  annual  incidence  in  Denmark  is  less  than  1  per
00  000  inhabitants,7 whereas  in  New  Mexico,  it  is  about  30
er  100  000  inhabitants,9 and  a  prospective  study  carried  out
n  India  revealed  that  HP  is  the  most  common  interstitial  lung
isease  (47.3%  of  cases).10
Several  HP  diagnostic  criteria  have  been  proposed,  but
one  of  them  so  far  has  been  validated.  However,  a  recent
tudy,  using  the  modiﬁed  Delphi  method,  identiﬁed  some
riteria  for  chronic  HP  that  achieved  consensus  among  inter-
ational  experts.11 Diagnosis  is  based  on  integration  of
linical,  radiological,  and  pathological  data.12 Identiﬁcation
f  causal  antigen  is  crucial,  not  only  for  diagnosis,  but  also
or  prevention  and  even  prognosis  of  disease.  However,  this
ssue  represents  a  major  challenge,  mostly  because  of  the
ack  of  standardized  techniques.5
In  this  sense,  this  report  aims  to  provide  an  overview  of
he  antigen’s  role  in  HP,  highlighting  its  diversity,  research
ethods,  and  prevention  strategies,  as  well  as  the  impact
n  disease  prognosis  due  to  elimination  of  the  antigen.
rom antigen to disease
he  ﬁrst  descriptions  of  a  pulmonary  disease  similar  to  HP,
s  it  is  known  today,  appeared  in  1713,  associated  with
eople  who  worked  with  cereals.13 However,  it  was  only
n  1932  that  Campbell  ﬁrst  described  Farmer’s  lung  (FL),
 disease  that  became  the  classic  example  of  HP.14 In  1959,
he  respiratory  disease  was  described  in  mushroom  work-
rs  caused  by  the  inhalation  of  compounds  contaminated
y  thermophilic  actinomycetes.15 In  1960,  the  disease  was
escribed  in  workers  who  come  in  contact  with  birds,  ini-
ially  associated  with  ducks  and  turkeys,  and  later  also  withPlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
arakeets  and  pigeons  (Bird-breeder’s  lungs).16 From  this
ate  onward,  other  agents  were  progressively  reported  as
aving  a  direct  contribution  to  the  onset  of  this  disease,  hav-
ng  currently  identiﬁed  more  than  200  causal  antigens.2,3 HP
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nly  develops  in  a  small  proportion  of  individuals  exposed  to
ausal  antigens;  in  fact,  when  exposed  to  the  same  causal
gent,  most  individuals  are  only  sensitized,  leading  to  a
mall  increase  in  lymphocytes  locally,  but  without  clinical
elevance,  which  suggests  the  existence  of  the  host’s  intrin-
ic  factors  in  its  pathogenesis4,5,17,18 (Fig.  1).
The  coexistence  of  triggering  (e.g.,  antigen  exposure)
nd  promoting  factors,  such  as  major  histocompatibility
omplex  (MHC  II)  gene  polymorphisms,  low-molecular-
eight  proteasomes,  transporters  associated  with  antigen
rocessing-1  (TAP1),  or  other  exposures,  such  as  viruses,
ay  lead  to  the  development  of  an  exacerbated  immune
eaction  resulting  in  persistent  lung  inﬂammation.3,18 In
act,  the  inhalation  of  causal  antigen  leads  to  an  inﬂam-
atory  reaction,  with  the  release  of  cytokines  and
roinﬂammatory  mediators,  among  others,  type  1  T  helper
Th1),  tumor  necrosis  factor-  (TNF-), interleukin-12
IL-12),  and  interferon  gamma  (INF-).19 Thereafter,  the
ontinued  exposure,  local  antibody  production,  and/or  the
resence  of  genetic  susceptibility  lead  to  critical  changes  in
he  lung,  namely,  ﬁbroblast  expansion  and  activation,  and
xtracellular  matrix  deposition18 (Fig.  1).
An  interesting  aspect  to  highlight  is  that  HP  is  less  fre-
uent  in  cigarette  smokers.  In  fact,  nicotine  is  thought  to
nhibit  macrophage  activation,  and  lymphocyte  proliferation
nd  function,  but  this  does  not  apply  to  ex-smokers.20 On  the
ther  hand,  in  smokers  who  develop  HP,  ﬁbrosing  disease
ith  a  worse  prognosis  is  more  common.21
The  clinical  behavior  of  HP  can  be  traditionally  divided
nto  three  distinct  phenotypes:  acute,  subacute,  and  chronic
Table  1).  There  is  a  considerable  controversy  surrounding
his  classiﬁcation,  because  no  widely  accepted  criteria  exist
o  distinguish  the  various  stages.  In  fact,  the  subacute  form
s  considered  by  some  authors  as  a  variant  of  acute  HP.1,4
acasse  et  al.22 performed  a  cluster  analysis,  suggesting  that
P  patients  should  be  classiﬁed  into  only  one  of  the  two  cat-
gories,  based  on  clinical  evaluation,  pulmonary  function
ests,  and  high-resolution  computed  tomography  ﬁndings.
ther  authors  have  proposed  an  alternative  classiﬁcation
hat  includes  acute  or  episodic  HP,  chronic  HP  with  acute
pisodes,  and  chronic  HP  without  acute  episodes.23 More
ecently,  Vasakova  et  al.6 proposed  a  novel  HP  classiﬁca-
ion  into  two  main  categories:  acute/inﬂammatory  HP  and
hronic/ﬁbrotic  HP,  based  on  clinical--radiologic--pathologic
orrelation,  with  a  considerable  prognostic  value.
ntigenic diversity
s  already  mentioned,  HP  may  be  induced  by  a  wide  and
rowing  variety  of  antigens,  which  can  be  divided  into  six
road  categories:  bacteria,  fungi,  mycobacteria,  animal  and
lant  proteins,  chemicals,  and  metals,  represented  by  dis-
ase  prototypes3 (Table  2).
The  list  of  HP-associated  environments  is  increasing,  but
n  most  situations,  the  disease  is  caused  by  similar  anti-
ens  in  distinct  environments.19 Recently,  Millon  et  al.24
ave  shown  the  existence  of  common  antigenic  amino  acid.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
equences  in  orthologous  proteins  from  a  fungus  belong-
ng  to  Mucorales  order  and  a Mycobacterium  species,  each
ne  acting  as  a  main  etiologic  agent  of  a speciﬁc  HP
orm.  The  existence  of  common  epitopes  in  orthologous
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hypersensit ivity 
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T cell-mediated
hypersensit ivity 
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Fibrosis
Figure  1  Pathogenesis  of  HP.  (A)  Classical  immunopathological  mechanisms  proposed  for  HP  (adapted  from  Delgado  et  al.96).
The coexistence  of  genetic  or  environmental  promoting  factors  leads  to  the  development  of  an  exaggerated  immune  reaction
that results  in  marked  lung  inﬂammation.  The  generation  of  the  granulomatous  inﬂammation  requires,  among  others,  the  expres-
sion of  Th1  cytokines,  including  TNF-,  IL-12,  and  IFN-.18 (B)  Persistent  antigen  exposure  and  sensitization  associates  with  local
antigen--antibody  complex  deposition,  macrophage  activation,  mononuclear  cell  recruitment,  and  predominant  Th1  cell-mediated
response; continuous  exposure  leads  to  critical  changes  in  the  lung,  ending  in  ﬁbrosis.4,18.
Table  1  Clinical  classiﬁcation  of  HP.1,17
Acute/subacute  HP  Chronic  HP
Exposure  to  causal
antigen
Intermittent  high-level  exposure  (the  subacute  form  develops
more  insidiously  and  it  is  caused  by  a  more  prolonged  and  less
intense exposure  to  the  agent  compared  with  the  acute  form)
Continuous  low-level  exposure
Onset of  symptoms  4--8  h  or  days  after  exposure  Insidious,  over  weeks  to  months
Signs and
symptoms
Cough,  dyspnea,  asthenia,  malaise,  and  fever  Cough,  dyspnea,  asthenia,  and  weight
loss
Physical
examination
Bilateral widespread  crackles;  sometimes  auscultation  is
normal
Inspiratory  crackles,  cyanosis,  and  cor
pulmonale
Outcome Symptoms  decrease  in  a  few  hours  or  even  days,  after  eviction
of causative  agent.  Exacerbations  may  occur  when  the  subject
is again  exposed  to  the  allergen-containing  environment
End-stage  ﬁbrotic  disease  and/or
emphysema;  exacerbations  may  occur
despite  avoidance  of  exposure
c
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iHP, hypersensitivity pneumonitis.
s immunogenic  proteins  from  microorganisms  belonging  to
greatly  different  phylogenetic  families  explains  how,  in  some
cases  of  HP,  a  growing  number  of  etiologic  agents  have  been
found  in  the  same  disease.24 HP  can  effectively  arise  in  any
environment,  including  workplace,  home,  and  recreational
activities,  where  bacteria  and  fungi  grow  or  birds  are  kept.25
Further,  drugs  can  also  cause  HP,  constituting  a  noninhal-
ing  variant  of  the  disease.  Although  it  is  a  rare  cause,  and
therefore  it  was  not  highlighted  in  this  paper,  the  number  of
HP-associated  drugs  is  increasing,  with  more  than  380  drugs
already  reported26--29;  therefore,  it  is  extremely  relevant  to
exclude  this  cause,  frequently  missed.  The  individuals  with
a  higher  risk  of  developing  HP  are  those  working  in  agricul-
ture,  poultry,  and  livestock  industries;  workers  using  ﬂuid
metals;30--32 cheese,  sausages,  or  ﬂour  processing;33--35 and
malt  or  soy  sauce  manufacturers.36 The  risk  also  increasesPlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
during  wood  processing  (e.g.,  cork  oak  bark)  and  construc-
tion;  textiles,  clothing,  or  plastics  manufacturing;  and  even
in  individuals  who  work  with  paints,  paint  hardeners,  or
other  chemical  products.37,38 However,  in  about  30--60%  of
c
p
a
gases,  the  antigen  remains  hidden  or  unrecognized,  some
uthors  have  even  suggested  the  use  of  ‘‘cryptogenic  HP’’
or  such  patients.6,39
ypes of disease according to antigen class
acterial  exposure
armer’s  lung  (FL)  is  considered  the  HP  prototype.  Although
t  is  still  underdiagnosed,  this  is  one  of  the  most  prevalent
ypes  of  disease,  and  where  bacteria  are  most  commonly  the
esponsible  antigens.  This  form  of  the  disease  is  triggered  by
nhalation  of  antigens  from  housed  microorganisms,  in  high
umidity  conditions,  in  hay,  straw,  and  grain  dust  stored
n  agricultural  yards.30 FL  responsible  antigens  vary  from.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
ountry  to  country  and  depend  on  climate,  farming,  and
roduction  conditions.40 Thermophilic  actinomycetes,  such
s  Saccharopolyspora  rectivirgula, Thermoactinomyces  vul-
aris,  Thermoactinomyces  viridis, and  Thermoactinomyces
Please  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
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Table  2  Causal  antigens  of  HP.4,6,35,56,57
Speciﬁc  antigens  Sources  Type  of  disease
Bacteria
Acinetobacter  spp.  Contaminated  water,  contaminated
machine  ﬂuid
Machine  operator’s  lung
Achromobacter  Contaminated  humidiﬁers Humidiﬁer  lung
Bacillus spp.  Contaminated  humidiﬁer  water,  sawdust,
moist
Woodworker’s  lung,  humidiﬁer  lung
Erwinia herbicola
Lichtheimia  corymbifera
S. rectivirgula
Streptomyces  thermohygroscopicus
T.  vulgaris
T.  viridis
T.  sacchari
Moldy  hay,  grain  Farmer’s  lung
Streptomyces  albus  Contaminated  compost,  edible  mushroom
manure,  hay  dusty  soil
Farmer’s  lung,  mushroom  grower’s
lung
T. sacchari  Moldy  sugarcane,  hay,  straw,  moldy  plants  Bagassosis,  farmer’s  lung
Fungi/yeasts
A. corymbifera Hay,  straw,  plant  material,  contaminated
humidiﬁers
Farmer’s  lung,  humidiﬁer  lung
Alternaria alternata Contaminated  humidiﬁers,  wood  pulp,  dust Humidiﬁer  lung,  woodworker’s  lung
Aspergillus spp.  (e.g.  A.  fumigatus,
A. niger)
Contaminated  barley,  hay,  straw,  moldy
plants,  mushrooms,  cheese.  Contaminated
houses,  humidiﬁers,  molds  on  the  walls
Farmer’s  lung,  mushrooms  worker’s
lung,  cheese  workers’  HP;  domestic
HP,  humidiﬁer  lung
A. oryzae  Aspergillus  enzyme  in  baking  agents,  soy  Fungal  alveolitis,  soya  dust  alveolitis
Aureobasidium  spp.  Contaminated  sauna  water,  domestic
ventilation,  and  cooling  systems,  steam  iron
water,  potted  ﬂowers,  greenhouse
Humidiﬁers  lung,  indoor  fountain  HP,
sauna  taker’s  lung,  steam  iron  lung
Botrytis cinerea  Mold  on  grapes  Wine-grower’s  lung
C. albicans  Saxophone  Sax  lung
Cephalosporium  spp.  Contaminated  basement,  contaminated
humidiﬁer,  potted  ﬂowers,  greenhouse
Humidiﬁer  lung,  Japanese
summer-type  HP
C. sitophila  Moldy  cork  Suberosis
Cryptococcus  albidus,  C.  neoformans  Contaminated  houses  Summer  type  HP
Cladosporium  herbarum,  C.
cladosporioides
Mold  on  ceiling  Mold  alveolitis,  indoor  air  HP,  Hot-tub
lung
E. amstelodami  Contaminated  humidiﬁers,  hay  Humidiﬁer  lung,  Farmer’s  lung
Fusarium culmorum  Ultrasound  nebulizers  Indoor  fountain  HP
Fusarium spp.  Molds  in  living  and  working  spaces,  molds
on plants
Indoor  air  alveolitis;  humidiﬁer  lung
Mucor spp.  Moldy  wood,  contaminated  humidiﬁers,
sawdust
Woodworker’s  lung;  cork  worker’s
lung,  humidiﬁer
Mucor stolonifer  Moldy  paprika  pods  Paprika  slicer’s  lung  historical
Penicillium  casei  Moldy  cheese,  white  coating  on  salami,
contaminated  humidiﬁers
Cheese  washer’s  lung,  humidiﬁers
lung,  salami  producer’s  lung
P. glabrum  Moldy  cork,  white  coating  on  salami,  molds
in apartments
Salami  producer’s  lung,  cork  worker’s
lung (suberosis),  summer-type  HP
Penicillium spp.  Contaminated  basement,  moldy  cork,  molds
on fruits  and  vegetables
Basement  lung,  onion  worker’s  lung,
potato  worker’s  lung,  fruit  grower’s
lung,  suberosis
Saccharomyces  cerevisiae  Baker’s  yeasts,  brewer’s  yeasts,  wine  yeasts  Farmer’s  lung,  yeast  powder
alveolitis
T. cutaneum  Contaminated  houses  Summer-type  HP
Trochoderma  viridae  Molds  in  ultrasound  nebulizers,  potted
ﬂowers,  greenhouses,  mold  on  wood,  paper,
citrus fruits
Indoor  air  alveolitis,  humidiﬁer  lung
W. sebi  Hay,  straw,  plant  material  Farmer’s  lung
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Table  2  (Continued)
Speciﬁc  antigens  Sources  Type  of  disease
Mycobacteria
NTM  (M.  immunogenum,  M.  avium
complex,  M.  chelonae,  M.  fortuitum,
M.  abscessus)
Contaminated  machine  ﬂuids,  cutting
ﬂuids,  cutting  oils,  wind  instruments,
contaminated  water,  whirlpools
Hot  tub  lung,  Whirlpool  alveolitis,
Machine  operator’s  lung,  wind
instrument  alveolitis
Animal proteins
Animal  fur  dust  Animal  pelts  Furrier’s  lung
Avian droppings,  serum  and  feathers  Parakeets,  canaries,  budgerigars,  pigeons,
parrots,  chicken,  turkeys,  geese,  ducks,
wild birds,  pheasants
Bird  fancier’s  lung
Avian feathers Feathers  beds,  pillows,  duvets Feather  duvet  lung
Fish meal  Animal  feed  Fish  meal  alveolitis
Protozoans  Contaminated  air  conditioners  Humidiﬁer  lung
Plant proteins
Grain  ﬂour  (wheat,  rye,  oats,  maize)  Flour  dust  Flour  dust  alveolitis
Legumes (soy) Legumes  (soy)  Soya  dust  alveolitis
Paprika Paprika  dust  Paprika  splitters  lung
Chemicals
Acid anhydrides,  isocyanates  Polyurethane  foams,  spray  paints,
elastomers,  glues,  adhesives,  mattress,  car
parts,  shoes,  elastic  synthetic  ﬁbers
Acid  anhydride  alveolitis,  isocyanate
alveolitis
Chloroethylene  Degreasing  agents,  cleaning  agents,
extraction  agents
Chemical  alveolitis
Methyl methacrylate  Dental  materials,  lacquer,  resin,  glues  Methacrylate  alveolitis
Triglycidyl  isocyanate  Powder  paints,  polyester  powder  Pinter’s  lung
Metals
Beryllium Batteries,  computers  neon  Beryliosis
Cobalt Hard  metal  alloys  Hard  metal  lung  disease
Zinc Zinc  fumes  Zinc  fumes  alveolitis
ria.
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uHP, hypersensitivity pneumonitis; NTM, nontuberculous mycobacte
sacchari,  are  the  most  frequently  described  agents.30,41
However,  in  some  cases,  FL  disease  results  from  fungal  expo-
sure,  such  as  Alternaria, Aspergillus  fumigatus,  and  Botrytis
species.42 Further,  Reboux  et  al.  (2006)  identiﬁed  Absidia
corymbifera,  Eurotium  amstelodami, and  Wallemia  sebi  as
the  main  causal  agents  of  FL  in  France.43 In  fact,  all  these
organisms  typically  reproduce  at  high  humidity  zones  and
temperatures  of  40--60 ◦C;  therefore,  this  form  of  HP  is  most
frequent  in  regions  where  agriculture  predominates,  espe-
cially  during  rainy  and  hot  seasons.43 Although  the  disease
prevalence  in  exposed  farmers  is  not  well  known,  several
studies  have  reported  similar  ﬁndings,  placing  the  preva-
lence  in  0.5--4.4%.44,45
Fungal  exposure
Molds  have  been  described  for  years  as  a  common  cause
of  occupational  HP.46 In  fact,  a  mold  is  a  type  of  fun-
gus  that  grows  in  damp  areas;  it  releases  tiny  particles,
commonly  called  as  spores,  which  can  be  harmful  whenPlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
breathed  in.47 Mold-induced  HP  has  been  increasingly
reported  as  being  caused  by  humidiﬁers,  heating,  and  venti-
lation  systems  contaminated  by  Aspergillus, Cladosporium,
Penicillium, Aureobasidium  pullulans,  Cephalosporium,  or
a
a
8
Aucor  species46 (Table  2).  However,  molds  can  be  found
n  other  unexpected  home  reservoirs,  such  as  fruits  and
egetables,  leading  to  various  forms  of  HP,  such  as  onion
orker’s  lung,  potato  worker’s  lung,  or  fruit  grower’s  lung6;
oldy  tapestry  with  Penicillium, Cladosporium, or  Botry-
is  species;47 and  even  ﬂower  pots,  whose  inhalation  of
old  spores  containing  Pullularia  pullulans,  Trichoderma
iride,  Cephalosporium  acremonium, or  A.  fumigatus  may
ead  to  HP.48 All  these  exposure  sources  can  go  completely
nnoticed  in  a  domestic  environment  and  are  possibly  more
requent  than  widely  recognized.  So,  a  thorough  inspection
f  the  whole  house  is  advisable  in  search  of  mold  stains,
ven  of  unnoticed  size,  humidity,  condensation,  or  a  musty
dor.46,49
Summer-type  HP  (SHP)  is  the  most  common  form  of
omestic  HP  in  Japan,  especially  in  the  western  and  south-
rn  parts  of  the  country;  some  cases  have  also  been  reported
n  other  Asian  countries.50 SHP  is  caused  by  repeated  inhala-
ion  of  fungi  Trichosporon  species,  namely,  Trichosporon
utaneum,  which  contaminates  domestic  environments,
sually  wooden  houses,  during  hot  and  humid  summers,  and.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
fter  a  rainy  season.50,51 T.  cutaneum  develops  at  temper-
tures  between  25  and  28 ◦C  and  a relative  humidity  above
0%,  especially  in  the  presence  of  wet  wood  or  vegetation.51
n  epidemiological  study  on  HP  performed  in  Japan  in  the
 IN PRESS+ModelP
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Table  3  Birds  associated  with  bird  fancier’s  lung.31
Order  Animals
Anseriformes  Ducks,  geese
Columbiformes  Pigeons
Galliformes  Chickens,  partridges,  pheasants,  turkeys
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980s  showed  that  the  proportion  of  SHP  cases  in  patients
ith  HP  was  74.4%.52 However,  more  recently,  Iijima  et  al.53
eriﬁed  that  the  incidence  seems  to  be  decreasing,  mainly
ue  to  changes  in  residential  environments,  although  cli-
atic  conditions  in  any  year  may  cause  a  temporary  increase
n  the  incidence  rate.
Suberosis,  also  known  as  corkhandler’s  disease  or  cork-
orker’s  lung,  is  another  form  of  HP  caused  by  fungi  existing
n  the  working  environment;  it  occurs  in  cork  workers  and
as  been  mainly  reported  in  Portugal.54--58 Cork  oak  is  the
econd  most  dominant  forest  species  in  Portugal,  making  this
ountry  the  world’s  leading  exporter  of  cork,  followed  by
pain.59,60 The  processes  used  in  cork  manufacture  depend
n  the  end  product  to  be  obtained;  however,  during  this
rocess,  workers  are  exposed  to  a  heavily  contaminated
nvironment  with  moldy  cork  dust.56 The  most  frequent  cork
olonizing  fungi  during  its  industrial  processing  are  Penicil-
ium  glabrum  (formerly  known  as  Penicillium  frequentans)
nd  Chrysonilia  sitophila.  P.  glabrum  is  the  main  causative
gent  of  suberosis,  but  during  the  storage  period,  cork  can
lso  be  colonized  by  other  fungi,  such  as  A.  fumigatus  or
ucor  species.56,57 In  Portugal,  it  has  been  estimated  that
--19%  of  cork  workers  may  develop  suberosis.54,55
In  recent  decades,  several  other  different  forms  of  dis-
ase  caused  by  fungi  have  been  described  in  the  literature.
P  can  also  be  observed  in  individuals  working  with  woods
olonized  by  fungi,  namely,  Aspergillus  and  Penicillium
pecies,  Cryptostroma  corticale,  Alternaria  species,  among
thers.  The  ﬁrst  cases  were  reported  when  conventional  out-
oor  drying  of  wood  was  replaced  by  indoor  drying  in  special
vens,  as  well  as  in  the  indoors  wood  sorting  and  cutting,  to
mprove  working  conditions  in  sawmills.37
Some  cases  have  been  reported  in  food  industry  workers,
uch  as  bakers  who  are  exposed  to  ﬂour  on  a  daily  basis,
hich  can  be  contaminated  with  the  fungi  A.  fumigatus;34
heese  producers  can  also  develop  cheese  workers’  HP
aused  by  Penicillium  notatum,  Penicillium  viridicutum,
.  fumigatus,  Aspergillus  niger, or  A.  pullulans35;  in  soy
auce  brewer,  where  precipitin  against  Aspergillus  oryzae
as  found  (soya  dust  alveolitis);6,36 and  even  in  salami  fac-
ory  workers  due  to  inhalation  of  dried  sausage  dust.  Morell
t  al.,33 for  example,  described  ﬁve  Spanish  patients  work-
ng  in  dry  sausage  production  with  Salami  Brusher’s  disease,
aused  by  P.  glabrum  and  A.  fumigatus.
In  conclusion,  fungal  exposure  can  have  various  sources,
ariable  in  frequency  but  highly  troublesome;  so,  there
hould  be  increasing  awareness  of  the  importance  of  detect-
ng  them  in  any  patient’s  daily  activities,  such  as  for
nstance,  musicians,  mainly  saxophonists  who  may  inhale
ungi,  Candida  albicans,  Phoma  species,  or  Ulocladium
otrytis,  present  in  the  instrument  mouthpiece  (Sax  Lung
isease).61
nimal  proteins  exposure
ird  fancier’s  lung  (BFL),  or  bird  breeder’s  disease,  is  a  com-
lex  syndrome  caused  by  the  repeated  inhalation  of  avianPlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
roteins  through  the  form  of  bird  droppings,  feathers,  or
ecretions,  triggering  an  exaggerated  immune  response  to
he  antigen  and  consequent  HP  in  sensitized  individuals.62
ess  often,  the  inhalation  may  occur  from  feathers  of  duvets
t
m
nPasseriformes Canaries
Psitacciformes  Budgerigars,  cockatoos,  parrots
r  pillows.63 BFL  is  most  frequently  reported  after  expo-
ure  to  pigeons  and  birds  belonging  to  the  Psittaciformes
rder,  including  cockatoos,  parakeets,  and  parrots.  Else-
here,  some  cases  of  BFL  resulting  from  poultry  exposure,
ncluding  chickens,  turkeys,  geese,  and  ducks,  have  also
een  reported31,64 (Table  3).
The  prevalence  of  this  form  of  disease  varies  geograph-
cally,  which  might  be  partially  explained  by  the  local
limate,  availability  of  medical  resources,  local  cultural
abits,  racial  factors,  smoking  habits,  and  even  exposure
uration  and  intensity.  However,  it  is  known  that  BFL  is
he  most  common  form  of  HP  worldwide,  corresponding  to
6--68%  of  all  HP  forms,31 with  a  prevalence  ranging  from  6  to
0%  in  exposed  pigeon  breeders.62 In  Portugal,  some  studies
ave  reported  a  prevalence  of  BFL  ranging  from  2  to  5%.65,66
n  the  other  hand,  the  acute,  subacute,  and  chronic  presen-
ations  of  BFL  have  also  been  recognized,  but  often  overlap
linically  to  each  other.  In  any  case,  a  continuous  antigen
xposure  in  chronic  phase  presents  worse  prognosis.31
ycobacterial  exposure
ot  tub  baths  have  become  increasingly  common  in  homes,
s  well  as  in  hotels  and  spas.  Recently,  these  baths  have
een  associated  with  an  emerging  disorder,  known  as  Hot
ub  Lung  (HTL).67
HTL  is  a  lung  disease  which  can  be  caused  by  the  inhala-
ion  of  hot  water  aerosols  from  hydromassage  baths  (the
ost  common  cause  found  in  literature)  and  can  also  occur
n  public  recreational  water  facilities,  such  as  swimming
ools,  saunas,  and  spas,  because  these  waters  are  contami-
ated  by  nontuberculous  mycobacteria  (NTM),  in  most  cases
elonging  to  the  Mycobacterium  avium  complex  (MAC).67,68
MAC  mainly  consists  of  two  mycobacteria  species,
amely,  Mycobacterium  avium  and  Mycobacterium
ntracellulare.69 It  is  the  hydrophobic  nature  of  M.  avium
nd  M.  intracellulare  and  the  high  content  of  mycolic  acid
resent  in  their  cell  walls  that  makes  MAC  highly  resistant
o  disinfectants  commonly  used  in  swimming  pools  and  spas.
hey  withstand  temperatures  up  to  42 ◦C,  exceeding  the
igher  limit  of  temperature  established  in  spas.68 Glazer
t  al.70 reported  that  M.  avium  and  other  NTMs  were  found
n  72%  of  the  air  and  water  samples  randomly  collected
rom  18  swimming  pools;  concentrations  were  signiﬁcantly
ower  in  chlorine  and  bromide  disinfected  pools  than  in
hose  disinfected  with  hydrogen  peroxide  and  ultraviolet
ight..  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
A relatively  recent  example  of  HP  induced  by  mycobac-
eria  is  that  of  metal  workers  exposed  to  aerosolized
etalworking  ﬂuids  (MWF)  contaminated  with  NTM,
amely,  Mycobacterium  chelonae  and  Mycobacterium
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Hypersensitivity  pneumonitis:  Antigen  diversity  and  disease  
immunogenum. MWF  are  complex  mixtures  of  oil  and  water
commonly  used  as  refrigerants  and  lubricants  in  various
industries.32
Chemical  exposure
Chemically  induced  HP  is  an  uncommon  entity;  however,  sev-
eral  substances  capable  of  causing  the  disease  have  already
been  described6 (Table  2).  Acrylate  compounds,  such  as
methyl  methacrylate,  are  associated  with  an  increased  inci-
dence  of  HP  in  dentists.  This  increase  seems  to  be  associated
with  the  substitution  of  amalgam  ﬁllers  by  acrylate  ﬁllers
in  dental  care.71 On  the  other  hand,  isocyanates  are  highly
reactive  reagents,  widely  used  in  polyurethane  polymers
production  for  ﬂexible  and  rigid  foams,  such  as  elastomers,
adhesives,  surface  coatings,  and  paints.72 Several  cases  of
HP  caused  by  these  reagents  have  already  been  reported,
mainly  related  to  spray  painting  or  plastics  manufacturing.38
Other  compounds,  such  as  anhydrides  used  in  plastics,
paints,  resins,  and  glues,  and  also  triglycidyl  isocyanurate,
often  used  in  paints,  are  also  recognized  as  causing  HP.31,73
The  prevalence  of  isocyanate-induced  HP,  related  to  the
plastic  manufacturing  process,  is  1.3%  of  all  chronic  HPs  in
Japan,  only  three  cases  having  been  reported  over  a  10-year
period.72,74
Methods for antigen determination
The  identiﬁcation  of  the  causal  antigen  is  crucial  not  only  for
the  diagnosis,  but  also  for  establishing  preventive  measures
and  of  disease  prognosis.  All  available  tools  for  detecting
the  source  of  exposure  should  be  used.5
Clinical  history
The  ﬁrst  step  is  to  collect  a  highly  detailed  clinical  his-
tory  so  that  it  is  possible  to  uncover  or  to  assume  the
exposure  source,  either  in  domestic,  recreational,  or  work
setting.5 The  use  of  a  standardized  questionnaire  can  be  very
useful  in  identifying  exposures,  otherwise  undetected  in  a
more  informal  discussion  with  the  patient;  however,  these
questionnaires  need  validation  before  being  used  in  clinical
practice.6
Speciﬁc  antibodies
The  second  step  requires  the  use  of  laboratory  tests  to
conﬁrm  the  presence  of  immunologic  sensitization  to  a
suspected  antigen,  classically  using  a  precipitation  reac-
tion  between  patient’s  sera  and  causal  antigen  extracts  for
detection  of  speciﬁc  antibodies,  mainly  of  the  immunoglob-
ulin  G  (IgG)  class.5 The  presence  of  speciﬁc  IgG  antibodies
reﬂects  an  immune  response  to  a  speciﬁc  exposure,  indi-
cating  that  the  individual  had  a  sufﬁcient  level  of  exposure
to  the  antigen  to  develop  sensitization.  However,  in  itself,
this  aspect  is  not  sufﬁcient  to  establish  the  diagnosis,Please  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
because  many  asymptomatic  individuals  show  a  similar  level
of  humoral  responses.17 In  fact,  precipitins  are  only  an
exposure  marker.  Antibodies  precipitating  against  poten-
tial  antigens  may  be  present  not  only  in  serum  and
e
p
n
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ronchoalveolar  lavage  (BAL)  samples  from  individuals  with
P,  but  also  in  some  who  are  asymptomatic  although  exposed
o  the  same  antigens.  Up  to  40%  of  the  farmers  exhibit
ositive  serum  precipitins  in  the  absence  of  clinically  sig-
iﬁcant  manifestation  of  the  disease,  with  no  long-term
equelae,3 as  shown  by  one  study  evaluating  43  asymp-
omatic  milk  producers  who  had  serum  antibodies  speciﬁc
or  FL  antigens  and  did  not  develop  abnormal  lung  func-
ion  tests  during  a  20-year  follow-up  period.75 Nonetheless,
 positive  serum  antibody  testing  is  a  signiﬁcant  predictor
f  HP  (odds  ratio,  5.3;  95%  conﬁdence  interval,  2.7--10.4)76
lthough  the  absence  of  serum  precipitin  does  not  exclude
n  HP  diagnosis.2 Fenoglio  et  al.77 found  that  serum  pre-
ipitins  were  useful  for  diagnosing  acute  HP  induced  by
ungi  (predictive  negative  value,  81--88%;  predictive  posi-
ive  value,  71--75%).  There  are  several  laboratory  methods
or  qualitative  determination  of  speciﬁc  antibodies,  such  as
he  precipitation  reaction  of  the  double  immunodiffusion  of
uchterlony  or  combinations  with  immunoelectrophoresis,
s  well  as  those  for  quantitative  determination,  such  as,
nzyme-linked  immunosorbent  assay  (ELISA),  ImmunoCAP
®
r  Immulite
®
.  In  general,  the  results  obtained  using  these
ethods  differ  considerably78;  ELISA  is,  at  present,  the  most
requently  used.79--82 Sandoval  et  al.  (1990),  carrying  out  a
omparative  study  for  detection  of  speciﬁc  antibodies  in  BAL
f  patients  with  HP,  using  immunoelectrophoresis  and  ELISA,
ound  positivity  in  12  and  100%  of  the  cases,  respectively,
howing  its  usefulness  for  antibody  detection  against  pigeon
ntigens  in  ﬂuids  with  a  low  protein  content.81 In  another
tudy,  Simpson  et  al.  (1992)  revealed  that  the  ELISA  method
howed  greater  sensitivity  (nearly  to  103 times  higher)  than
he  double-immunodiffusion  method,  in  patients  with  BFL.82
uhara  et  al.80 also  reported  high  sensitivity  and  speciﬁcity
f  the  antibodies,  80--100  and  92--100%,  respectively,  in
cute  bird-related  HP,  claiming  that  antibody  titers  may  be
ower  in  chronic  bird-related  HP,  because  cellular  immu-
ity  is  more  closely  associated  with  chronic  bird-related  HP
athology  than  the  humoral  immunity.
There  is  a  long  list  of  potential  antigens  in  HP,  although
here  is  only  a  limited  number  of  available  antigen  prepa-
ations  proposed  for  detection  (Table  4).  The  selection  of
ntigens  to  be  tested  should  be  based  on  the  individual
xposure  history  and  in  the  most  prevalent  type  in  each
egion.6,78 In  fact,  the  serum-speciﬁc  IgG  (sIgGs)  panels  used
n  different  centers  is  determined  by  practice  location.  An
xample  of  a  sIgGs  panel  includes  molds,  bacteria,  animal
roteins,  and  chemical  substances,  as  illustrated  in  Table  4.
Currently,  clinicians  do  not  have  access  to  tests  that  allow
hem  to  individualize  the  panel  for  actual  exposure  on  their
atients.  In  addition,  the  speciﬁc  antibodies  are  not  always
dentiﬁed  in  patients  with  HP,  probably  because  some  of  the
ntigens  that  cause  this  condition  still  remain  unknown.83
he  ﬁnding  that  common  peptide  epitopes  may  induce  cross-
eactivity  in  HP  serodiagnosis  can  affect  test  performance
hen  searching  for  epitopes  that  are  common  to  different
icroorganisms  and  capable  of  inducing  the  same  antibody
esponse  in  patients  with  HP;  this  is  a  current  challenge.24
The  lack  of  reliable  standardized  techniques  and  of.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
stablished  physiological  intervals  for  sIgGs  levels  against
ossible  causal  antigens  raise  concerns  about  the  diag-
ostic  use  of  this  technique.5 It  would,  therefore,  be
dvantageous  to  involve  auxiliary  specialists,  occupational
ARTICLE IN PRESS+ModelPULMOE-54; No. of Pages 12
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Table  4  Some  common  antigen  panels  and  mixtures  available  for  speciﬁc  IgG  quantiﬁcation  to  evaluate  exposure/sensitization
in suspected  HP  (adapted  from  Vasakova  et  al.6).
Microorganism-related  antigens
Indoor  molds  mix  1:  P.  notatum,  Cladosporium  herbatum,  A.  fumigatus,  A.  alternata
Indoor molds  mix  2:  Penicilium  chrysogenum,  C.  herbatum,  Mucor  racemosus,  A.  alternata
Aspergillus  spp  mix:  A.  fumigatus,  A.  terreus,  A.  niger,  A.  ﬂavus
Farm microorganisms  mix:  Micropolyspora  faeni,  T.  vulgaris
A. alternata
A.  fumigatus
Cladosporium  herbatum
P.  glabrum  (frequentans)
Micropolyspora  faeni
T.  vulgaris
Bird-related  antigens
Poultry  feathers  mix:  goose,  hen,  duck,  turkey
Cage bird  feather  mix:  parrot,  budgerigar,  canary,  alexander,  ﬁnch
Bird feathers  mix:  goose,  hen,  ducks,  parrot
Budgerigar  antigens:  feather,  droppings,  serum
Pigeon  antigens:  feather,  droppings,  serum
Parrot  antigens:  feather,  droppings,  serum
Pigeon  serum
Pigeon  feathers
Canary  feathers
Chemical  antigens/haptens
Paint  polyester  chemicals  mix:  toluene  diisocyanate,  difenylmetan  diisocyanate,  hexametylen  diisocyanate,  phthalic
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hysicians,  and  industrial  or  environmental  hygienists  to
btain  more  reliable  samples  for  microscopic,  microbio-
ogical,  and  immunological  analysis.6 However,  despite  all
hese  limitations,  this  technique  is  essential  to  support  the
P  diagnosis,  sometimes  determinant  in  discovering  new
tiologies  of  the  disease,  as  well  as  providing  differential
iagnosis  between  HP  and  other  diseases,  such  as  idiopathic
ulmonary  ﬁbrosis  (IPF).75,84
peciﬁc  inhalation  challenge
 third  method  of  conﬁrming  causality  between  a  suspected
ntigen  and  the  disease  is  the  speciﬁc  inhalation  challenge
SIC),  which  presupposes  patient  exposure  to  the  potentially
ontaminated  environment  either  through  direct  inhalation
f  the  antigens  or  through  commercially  available  extracts.5
his  technique  has  also  been  used  to  conﬁrm  a  suspected
tiologic  agent  and  when  there  are  doubts  about  the  dif-
erential  diagnosis  of  chronic  HP  and  IPF.85 The  focus  of  SIC
s  to  demonstrate  that  exposure  to  a  particular  agent  pro-
uces  a  fall  in  forced  expiratory  volume  in  one  second  (FEV1)
hile  ensuring  that  fall  remains  within  safety  limits  and  does
ot  cause  serious  adverse  reactions.  Indeed,  most  authors
ecommend  that,  during  SIC,  exposure  should  be  increased
ery  gradually;  in  fact,  the  exposure  intensity  is  of  particularPlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
elevance  to  enhance  SIC  safety,  especially  with  previously
nknown  sensitizing  agents.  In  this  context,  it  would  be  very
seful  to  identify  patient  characteristics  that  predict  a  spe-
iﬁc  response  during  SIC.86 Morell  et  al.64 proposed  that  SIC
a
a
a
khould  be  considered  the  ‘‘gold  standard’’  among  nonin-
asive  BFL  diagnostic  examinations,  focusing  on  decreased
orced  vital  capacity  (FVC)  and/or  lung  diffusing  capac-
ty  for  carbon  monoxide  (DLCO).  In  fact,  this  test  reveals
ery  satisfactory  sensitivities  and  speciﬁcities  in  experi-
nced  centers.6 In  a  study  carried  out  by  Mun˜oz  et  al.,87
IC  evidenced  a  good  diagnostic  yield  in  113  patients  with
uspected  HP.  The  overall  sensitivity  and  speciﬁcity  were,
espectively,  73  and  84%,  when  tests  against  all  causative
gents  were  analyzed  together;  and  85  and  86%,  respec-
ively,  when  evaluating  results  in  patients  only  exposed  to
vian  or  fungal  antigens.  In  the  same  way,  Ishizuka  et  al.88
emonstrated  that  the  sensitivity  and  speciﬁcity  for  diagnos-
ng  chronic  BFL  were  as  high  as  92.9  and  94.7%,  respectively.
Despite  its  ‘‘gold  standard’’  status,  SIC  is  rarely  per-
ormed  because  it  is  neither  standardized  nor  validated,
ecause  specialized  centers  are  required  which  have  experi-
nce  in  the  procedure  and  proper  equipment  for  treatment
f  uncommon,  but  potential  complications.78
revention
voiding  exposure  to  causal  agent  is  the  cornerstone  of
P  management  and  an  important  and  determinant  factor
or  prognosis,  because  progression  is  largely  avoidable  with.  2018.  https://doi.org/10.1016/j.pulmoe.2018.07.003
ppropriate  antigen  eviction.3 Patients  should  be  advised
bout  the  relevance  of  a  clean  domestic  air  environment
nd  the  absolute  necessity  of  avoiding  further  exposures  to
nown  HP  causative  agents.  However,  eviction  is  difﬁcult
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for  most  patients  because  of  professional  or  personal  issues
(e.g.,  affective  links  to  a  pet  or  fear  of  abandoning  a
hobby).6 In  this  sense,  an  occupational  and  environmental
health  professional  should  carefully  recognize  individuals  at
risk,  identiﬁed  through  a  detailed  history  and  exposure  eval-
uation  in  the  workplace,  and  also  collaborate  with  partners
in  the  local  community  and  employers  to  raise  awareness
about  the  risks  of  antigen  exposure,  and  even  inform  them
about  preventive  measures.  Providing  simple  and  accessible
educational  material  can  also  help  to  reduce  exposure  and
to  facilitate  more  accurate  diagnosis,  as  well  as  to  incite  the
use  of  personal  protective  equipment,  including  masks  and
respirators.89
In  the  speciﬁc  case  of  FL  exposure,  there  are  three  possi-
bilities  for  reducing  repeated  inhalation  of  organic  particles
and,  thus  preventing  progression  to  a  ﬁbrosing  process:  (1)
deﬁnitive  withdrawal  of  patients  from  workplace,  which  in
most  situations  is  not  a  feasible  solution  for  economic  rea-
sons;  (2)  improve  the  storage  methods  for  hay  or  straw;  it
has  been  shown  that  storing  in  low-density  bundles  hinders
the  growth  of  microorganisms,  rather  than  round  bales  with
a  high  concentration  of  moisture  due  to  the  increased  hay
compaction;  (3)  use  of  really  efﬁcient  respiratory  protection
devices  capable  of  preventing  the  entry  of  antigens  into  the
bronchial  tree.30 In  the  case  of  pigeon  breeders,  they  might
be  encouraged  to  spend  less  time  in  the  loft  and  to  wear  a
hat  and  coat  which  can  be  removed  when  exiting  the  loft,
so  as  to  avoid  continuous  contact  with  the  antigen  that  can
be  carried  on  clothing  or  hair.  Increasing  the  level  of  ven-
tilation  in  the  loft  can  also  be  useful  in  reducing  antigen
exposure.17 In  respect  to  HTL,  the  World  Health  Organiza-
tion  recommends  that  treatment  and  prevention  methods
of  HP  caused  by  M.  avium  should  include  protection,  coagu-
lation,  ﬂocculation,  sedimentation,  ﬁltration,  disinfection,
and  protection  of  water  distribution  system.68
Prognosis
HP  evolution  is  highly  variable  and  depends  essentially  on
the  time  and  concentration  of  antigen  exposure.  Individu-
als  with  acute  form  of  the  disease,  but  who  were  detected
early  and  the  causal  antigen  was  immediately  evicted,  tend
to  have  an  excellent  prognosis.  In  chronic  forms,  a  partial
recovery  may  also  occur;  however,  in  some  cases,  the  dis-
ease  tends  to  progress,  leading  to  a  permanent  loss  of  lung
function,  irreversible  pulmonary  ﬁbrosis  and  death,  even
after  antigen  eviction  and  appropriate  treatment.6,91 For
example,  about  20%  of  the  acute  forms  of  FL  evolve  into
chronic  forms  and  are  irreversible30 and  fatal  HP  cases  have
been  reported  to  be  related  to  acute  exacerbations  after
chronic  exposure  to  some  antigens,  namely,  avian  protein
antigens,  thermophilic  actinomycetes,  molds,  heated  plas-
tics,  among  others.72,91,92
Mortality  data  are  scarce  in  the  literature;  however,  in
England  and  Wales,  from  1968  to  2008,  878  HP  deaths  were
reported,93 whereas  in  a  study  performed  in  Denmark,  5-
year  survival  rate  was  93%.7 In  chronic  HP,  the  averagePlease  cite  this  article  in  press  as:  Nogueira  R,  et  al.  Pulmonol
survival  rate  is  7  years.1
Factors  associated  with  a  poor  prognosis  include  longer
exposure  period,  high-intensity  antigen  exposure,  advanced
age,  smoking,  and  a  radiological  and/or  histological  pattern PRESS
ications  9
ith  ﬁbrosis.1,6,21,90,94 The  antigen  type  may  also  inﬂuence
he  prognosis,  because  there  are  some  data  suggesting  that
FL  may  have  a  worse  prognosis  than  FL.5 However,  Braun
t  al.95 suggest  that  exacerbations/relapses  are  the  factors
hat  most  inﬂuence  a  detrimental  evolution  long  term.  Fur-
her,  Fernandez-Pérez  et  al.39 following  up  142  HP  cases
eported  that  the  nonidentiﬁcation  of  antigen  was  associ-
ted  with  a  decrease  in  survival  from  18.2  to  9.3  years.
onclusion
P  occurs  only  in  a  small  number  of  individuals  exposed
o  causal  antigens.  Most  individuals  are  only  sensitized,
ecause  the  development  of  the  disease  is  based  on  the
nteraction  between  inducing  factors  (causal  antigen)  and
romoters,  itself  related  to  the  host  (genetic  background
nd  additional  environmental  factors),  leading  to  dysreg-
lation  of  the  immune  system  and  consequent  persistent
nﬂammation.
Several  forms  of  the  disease  have  been  described,  the
ost  common  being  caused  by  the  inhalation  of  bacte-
ia,  proteins,  fungi,  or  mycobacteria  present  in  the  host
nvironment,  such  as  workplace,  home  environment,  or
ecreational  activities.  Other  substances,  such  as  chemicals
namely,  isocyanates,  or  acrylates)  may  also  act  as  trigger-
ng  agents,  despite  being  less  commonly  associated  with  the
isease.
The  diagnosis  of  HP  should  be  based  on  a  proactive  search
or  potential  antigen  sources,  whose  identiﬁcation  is  often
ampered  by  the  lack  of  recognition  of  some  sources  and/or
y  the  absence  of  standardized  detection  methods  of  sen-
itization.  In  this  context,  it  would  be  legitimate  to  create
ultidisciplinary  public  health  teams  to  collect  and  to  eval-
ate  in  locus  potentially  suspicious  material.
Eviction  of  the  causal  agent  exposure  is  the  cornerstone
f  HP  management,  because  antigen  inhalation  maintenance
as  prognostic  implications,  with  the  consequent  progres-
ion  and  reduction  in  survival  rate.  In  this  way,  protection
easures  should  be  implemented,  in  particular,  at  the  level
f  the  individual  or  at  the  source  of  exposure  itself.  A  longer
xposure  period,  high  antigenic  intensity,  the  type  of  anti-
en,  and  the  unidentiﬁed  exposure  source  are  associated
ith  a  reserved  prognosis.
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